Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naive Subjects in Hunan Province, China

被引:13
|
作者
Zou Xiaobai [1 ]
Xi, Chen [1 ]
Tian, Hongping [2 ]
Williams, Ann B. [3 ]
Wang, Honghong [4 ]
He, Jianmei [1 ]
Zhen, Jun [1 ]
Chiarella, Jennifer [5 ]
Blake, Lisebeth A. [6 ]
Turenchalk, Gregory [6 ]
Kozal, Michael J. [5 ]
机构
[1] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China
[2] Yale China Assoc, New Haven, CT USA
[3] UCLA Sch Nursing, Los Angeles, CA USA
[4] Cent S Univ, Changsha, Hunan, Peoples R China
[5] Yale Univ, Sch Med, New Haven, CT USA
[6] 454 Life Sci, Branford, CT USA
来源
PLOS ONE | 2014年 / 9卷 / 06期
关键词
REVERSE-TRANSCRIPTASE INHIBITORS; MINORITY POPULATIONS; HIV-1; VARIANTS; THERAPY; FAILURE; GENOME;
D O I
10.1371/journal.pone.0098740
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: There are few data on the prevalence of WHO transmitted drug resistance mutations (TDRs) that could affect treatment responses to first line antiretroviral therapy (ART) in Hunan Province, China. Objective: Determine the prevalence of WHO NRTI/NNRTI/PI TDRs in ART-naive subjects in Hunan Province by deep sequencing. Methods: ART-naive subjects diagnosed in Hunan between 2010-2011 were evaluated by deep sequencing for low-frequency HIV variants possessing WHO TDRs to 1% levels. Mutations were scored using the HIVdb.stanford.edu algorithm to infer drug susceptibility. Results: Deep sequencing was performed on samples from 90 ART-naive subjects; 83.3% were AE subtype. All subjects had advanced disease (average CD4 count 134 cells/mm(3)). Overall 25.6%(23/90) of subjects had HIV with major WHO NRTI/NNRTI TDRs by deep sequencing at a variant frequency level >= 1%; 16.7%(15/90) had NRTI TDR and 12.2%(11/90) had a major NNRTI TDR. The majority of NRTI/NNRTI mutations were identified at variant levels <5%. Mutations were analyzed by HIVdb.stanford.edu and 7.8% of subjects had variants with high-level nevirapine resistance; 4.4% had high-level NRTI resistance. Deep sequencing identified 24(27.6%) subjects with variants possessing either a PI TDR or hivdb.stanford.edu PI mutation (algorithm value >= 15). 17(19.5%) had PI TDRs at levels >1%. Conclusions: ART-naive subjects from Hunan Province China infected predominantly with subtype AE frequently possessed HIV variants with WHO NRTI/NNRTI TDRs by deep sequencing that would affect the first line ART used in the region. Specific mutations conferring nevirapine high-level resistance were identified in 7.8% of subjects. The majority of TDRs detected were at variant levels <5% likely due to subjects having advanced chronic disease at the time of testing. PI TDRs were identified frequently, but were found in isolation and at low variant frequency. As PI/r use is infrequent in Hunan, the existence of PI mutations likely represent AE subtype natural polymorphism at low variant level frequency.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study
    Verbiest, W
    Brown, S
    Cohen, C
    Conant, M
    Henry, K
    Hunt, S
    Sension, M
    Stein, A
    Stryker, R
    Thompson, M
    Schel, P
    Van Den Broeck, R
    Bloor, S
    Alcorn, T
    Van Houtte, M
    Larder, B
    Hertogs, K
    AIDS, 2001, 15 (05) : 647 - 650
  • [22] The Prevalence of Transmitted Antiretroviral Drug Resistance in Treatment-Naive HIV-Infected Individuals in China
    Liao, Lingjie
    Xing, Hui
    Shang, Hong
    Li, Jingyun
    Zhong, Ping
    Kang, Laiyi
    Cheng, Hua
    Si, Xuefeng
    Jiang, Shulin
    Li, Xinping
    Shao, Yiming
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 53 : S10 - S14
  • [23] Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy
    Harrigan, PR
    Hogg, RS
    Dong, WWY
    Yip, B
    Wynhoven, B
    Woodward, J
    Brumme, CJ
    Brumme, ZL
    Mo, T
    Alexander, CS
    Montaner, JSG
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (03): : 339 - 347
  • [24] Short Communication: Transmitted HIV Drug Resistance in Antiretroviral-Naive Pregnant Women in North Central Nigeria
    Imade, Godwin E.
    Sagay, Atiene S.
    Chaplin, Beth
    Chebu, Philippe
    Musa, Jonah
    Okpokwu, Jonathan
    Hamel, Donald J.
    Pam, Ishaya C.
    Agbaji, Oche
    Samuels, Jay
    Meloni, Seema
    Sankale, Jean-Louis
    Okonkwo, Prosper
    Kanki, Phyllis
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 (02) : 127 - 133
  • [25] Transmitted drug resistance to rilpivirine among antiretroviral-naive patients living with HIV from northern Poland
    Parczewski, Milosz
    Urbanska, Anna
    Maciejewska, Katarzyna
    Witak-Jedra, Magdalena
    Leszczyszyn-Pynka, Magdalena
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17
  • [26] Genotypic HIV-1 drug resistance testing in antiretroviral-naive subjects in Houston, Texas
    Nannini, EC
    Han, XL
    O'Brien, WA
    Arduino, RC
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (03) : 317 - 319
  • [27] High prevalence of transmitted drug resistance in HIV-1-infected antiretroviral-naive patients from Conakry, Guinea-Conakry
    Diakite, M.
    Charpentier, C.
    Bellecave, P.
    Cisse, M.
    Peytavin, G.
    Djoudalbaye, B.
    Pizzarro, L.
    Katlama, C.
    Huber, F.
    Masquelier, B.
    Descamps, D.
    ANTIVIRAL THERAPY, 2010, 15 : A149 - A149
  • [28] Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France
    Assoumou, Lambert
    Bocket, Laurence
    Pallier, Coralie
    Grude, Maxime
    Ait-Namane, Rachid
    Izopet, Jacques
    Raymond, Stephanie
    Charpentier, Charlotte
    Visseaux, Benoit
    Wirden, Marc
    Trabaud, Mary-Anne
    Le Guillou-Guillemette, Helene
    Allaoui, Chakib
    Henquell, Cecile
    Krivine, Anne
    Dos Santos, Georges
    Delamare, Catherine
    Bouvier-Alias, Magali
    Montes, Brigitte
    Ferre, Virginie
    De Monte, Anne
    Signori-Schmuck, Anne
    Maillard, Anne
    Morand-Joubert, Laurence
    Tumiotto, Camille
    Fafi-Kremer, Samira
    Amiel, Corinne
    Barin, Francis
    Marque-Juillet, Stephanie
    Courdavault, Laurence
    Vallet, Sophie
    Beby-Defaux, Agnes
    de Rougemont, Alexis
    Fenaux, Honorine
    Avettand-Fenoel, Veronique
    Allardet-Servent, Annick
    Plantier, Jean-Christophe
    Peytavin, Gilles
    Calvez, Vincent
    Chaix, Marie-Laure
    Descamps, Diane
    Roussel, C.
    Le Guillou-Guillemette, H.
    Ducancelle, A.
    Courdavault, L.
    Alloui, C.
    Honore, P.
    Lepiller, Q.
    Bettinger, D.
    Bellecave, P.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (05) : 1417 - 1424
  • [29] Drug-resistance mutations in antiretroviral-naive patients with established HIV-1 infection in Mexico
    Escoto-Delgadillo, M
    Vázquez-Valls, E
    Ramírez-Rodríguez, M
    Corona-Nakamura, A
    Amaya-Tapia, G
    Quintero-Pérez, N
    Panduro-Cerda, A
    Torres-Mendoza, BM
    HIV MEDICINE, 2005, 6 (06) : 403 - 409
  • [30] A Multicenter Study of Initiation of Antiretroviral Therapy and Transmitted Drug Resistance in Antiretroviral-Naive Adolescents and Young Adults With HIV in New York City
    Gagliardo, Christina
    Brozovich, Ava
    Birnbaum, Jeffrey
    Radix, Anita
    Foca, Marc
    Nelson, John
    Saiman, Lisa
    Yin, Michael
    Carras-Terzian, Elektra
    West, Emily
    Neu, Natalie
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (06) : 865 - 872